Related Experiment Video
Updated: May 12, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Prognosis of vasculitis associated myelodysplasia
C Belizna1, J F Subra, D Henrion
1Internal Medicine Department, University Hospital Angers, 4 rue Larey, France. cristina.belizna@wanadoo.fr
Abstract:
Systemic and immune manifestations have been reported in patients with MDS. The correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients remains controversial. Most of the authors agree that the median survival in myelodysplastic syndrome is not related to the presence of systemic and immune manifestations, but only with the existence of a systemic vasculitis.
Related Concept Videos
Myocarditis III: Medical Management
Differentiation of Common Myeloid Progenitor Cells
Myocarditis I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
